Radiation-Immunotherapy Combination Can Slow Tumor Growth for Some Patients with Stage IV Cancer

 

According to results from a study presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), treatment with radiation therapy and immunotherapy can stop the growth of tumors by stimulating the body’s immune system to attack the cancer. In the study, one hundred patients with stage IV cancer that had spread […]

 

Learn More

 

 

Women’s Health Night

 

New Jersey CyberKnife and Community Medical Center invite you to join them for Women’s Health Night on Tuesday, November 28th.  This free community event will feature presentations on women’s health and preventative care, screening recommendations, and much more.  Join us and bring a woman you care about in your life to this informative event!  

 

Learn More

 

 

Adding Radiation to Chemotherapy May Dramatically Improve Survival for Advanced-Stage NSCLC Patients

 

According to a new clinical trial reported at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), combining radiation therapy with chemotherapy for patients with limited stage IV non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to lung cancer patients who only receive chemotherapy. Lung cancer claims the […]

 

Learn More

 

 

10-year Data Shows CyberKnife Provides Excellent Long-term Control of Low-Risk Prostate Cancer

 

Accuray, the company that develops and manufactures the CyberKnife® Robotic Radiosurgery System, the system that New Jersey CyberKnife uses to treat cancer, recently announced the results of the first study that evaluated the use of stereotactic body radiation therapy (SBRT) in low-risk prostate cancer 10 years post treatment. The study titled, “Stereotactic Body Radiotherapy for […]

 

Learn More

 

 

New Jersey CyberKnife Breast Radio Spot

 

If you are considering radiation therapy for breast cancer treatment after surgery, you need to consider New Jersey CyberKnife.

 

Learn More

 

 

Targeted Radiotherapy Limits Side Effects of Breast Cancer Treatment

 

According to study results published in The Lancet, a weekly peer-reviewed general medical journal, breast cancer patients who have radiotherapy targeted at the original tumor site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return. The researchers at 30 radiotherapy […]

 

Learn More

 

 

New Data Supports Use of SBRT in Elderly Patients with Early-Stage Lung Cancer

 

New data from a recent study titled “Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer” demonstrated that stereotactic body radiation therapy (SBRT) is a safe treatment option for early-stage lung cancer patients aged 80 or older. The study, which was published in The Red Journal, the official journal […]

 

Learn More

 

 

ASTRO Issues Guidelines for Using High-dose Focused Radiation in Early-stage Lung Cancer

 

The American Society for Radiation Oncology (ASTRO), the premier radiation oncology society in the world for health care professionals who specialize in treating patients with radiation therapies, has released new guidelines for treating inoperable lung cancer patients with stereotactic body radiation therapy (SBRT). The report, “Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung […]

 

Learn More

 

 

After Work – CyberKnife for Prostate

 

 

Learn More

 

 

New Jersey CyberKnife Accepting Patients for Partial Breast Irradiation Study

 

According to the American Cancer Society, about 1 in 8 women in the U.S. will develop breast cancer during their lifetime. Survival rates from breast cancer have been increasing since about 1989, with larger increases in women younger than 50.  These increases are believed to be the result of earlier detection through screening and increased […]

 

Learn More